Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether
- 28 September 2007
- journal article
- Published by Wiley in Cancer Science
- Vol. 98 (12) , 1959-1964
Abstract
With limited treatment options, intraperitoneal spread of ovarian cancer is a common problem leading to high morbidity. Intraperitoneal photodynamic therapy combined with debulking surgery to treat residual disease is an alternative choice for clinicians. Hematoporphyrin monomethyl ether (HMME) is a promising second‐generation photosensitizer developed in China. Our study was designed to investigate the phototoxicity of HMME on ovarian cancer. NuTu‐19, a cell line derived from adenocarcinoma of Fischer 344 rat, and its allogeneic graft ascites tumor model was used in this study. HMME was confirmed to be localized in cytolysosome, and HMME‐based photosensitization induced direct necrosis as well as mitochondria damage. The photocytotoxicity of HMME was both light‐ and drug dose‐dependent and no significant dark cytotoxicity was observed in NuTu‐19 cells. With the ascite tumor‐bearing Fischer 344 rat model, HMME‐based intraperitoneal photodynamic therapy was proved to be useful in improving the prognosis of ovarian cancer. Thus, this study provides evidence that HMME‐based photodynamic therapy is an effective adjuvant therapy for ovarian cancer. (Cancer Sci 2007; 98: 1959–1964)Keywords
This publication has 28 references indexed in Scilit:
- Photodynamic Therapy in OncologyThe Oncologist, 2006
- A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and SarcomatosisClinical Cancer Research, 2006
- Phototoxicity of Hemoporfin to ovarian cancerBiochemical and Biophysical Research Communications, 2005
- Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevationCancer Letters, 2004
- Intracellular signaling mechanisms in photodynamic therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- Phase II Trial of Debulking Surgery and Photodynamic Therapy for Disseminated Intraperitoneal TumorsAnnals of Surgical Oncology, 2001
- Highly Selective Targeting of Ovarian Cancer with the Photosensitizer PEG‐m‐THPC in a Rat ModelPhotochemistry and Photobiology, 1999
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- Photodynamic therapy of the canine peritoneum: Normal tissue response to intraperitoneal and intravenous photofrin followed by 630 nm lightLasers in Surgery and Medicine, 1991